Atlas Trials

A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity

Clinical trial NCT03785223 · COMPLETED

Trial details

NCT number
NCT03785223
Sponsor
McMaster University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Attention Deficit Hyperactivity DisorderGeneralized Anxiety DisorderSocial Anxiety DisorderPanic DisorderAgoraphobia
Start date
2019-04-20
Primary completion
2022-09-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.